ES8302732A1 - Procedimiento para la obtencion de una 4-aminoimidazolo(4,5-c,7)-rifamicina sv o s. - Google Patents

Procedimiento para la obtencion de una 4-aminoimidazolo(4,5-c,7)-rifamicina sv o s.

Info

Publication number
ES8302732A1
ES8302732A1 ES505723A ES505723A ES8302732A1 ES 8302732 A1 ES8302732 A1 ES 8302732A1 ES 505723 A ES505723 A ES 505723A ES 505723 A ES505723 A ES 505723A ES 8302732 A1 ES8302732 A1 ES 8302732A1
Authority
ES
Spain
Prior art keywords
compound
type
rifamycines
imidazo
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES505723A
Other languages
English (en)
Spanish (es)
Other versions
ES505723A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES505723A0 publication Critical patent/ES505723A0/es
Publication of ES8302732A1 publication Critical patent/ES8302732A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES505723A 1980-09-25 1981-09-23 Procedimiento para la obtencion de una 4-aminoimidazolo(4,5-c,7)-rifamicina sv o s. Expired ES8302732A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH718480 1980-09-25
CH718580 1980-09-25

Publications (2)

Publication Number Publication Date
ES505723A0 ES505723A0 (es) 1982-12-01
ES8302732A1 true ES8302732A1 (es) 1982-12-01

Family

ID=25700906

Family Applications (2)

Application Number Title Priority Date Filing Date
ES505723A Expired ES8302732A1 (es) 1980-09-25 1981-09-23 Procedimiento para la obtencion de una 4-aminoimidazolo(4,5-c,7)-rifamicina sv o s.
ES514883A Granted ES514883A0 (es) 1980-09-25 1982-08-10 Procedimiento para la obtencion de una 4-aminoimidazolo 4,5-c-rifamicina svo s.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES514883A Granted ES514883A0 (es) 1980-09-25 1982-08-10 Procedimiento para la obtencion de una 4-aminoimidazolo 4,5-c-rifamicina svo s.

Country Status (13)

Country Link
EP (1) EP0049683A3 (member.php)
KR (1) KR830007667A (member.php)
AU (1) AU7559481A (member.php)
DD (1) DD204925A5 (member.php)
DK (1) DK421981A (member.php)
ES (2) ES8302732A1 (member.php)
FI (1) FI812936A7 (member.php)
GB (1) GB2084575A (member.php)
GR (1) GR75352B (member.php)
IL (1) IL63917A0 (member.php)
NO (1) NO813258L (member.php)
PL (1) PL233180A1 (member.php)
PT (1) PT73726B (member.php)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380839A (en) * 1985-09-12 1995-01-10 The Upjohn Company Phenylpiperazinyl steroids
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
GB8531887D0 (en) * 1985-12-30 1986-02-05 Lepetit Spa Rifamycin sv derivatives
IT1253711B (it) * 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1172155A (en) * 1967-03-01 1969-11-26 Lepetit Spa New Rifamycins
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
GB2069485B (en) * 1980-02-13 1983-11-23 Erba Farmitalia Rifamycin derivatives

Also Published As

Publication number Publication date
NO813258L (no) 1982-03-26
ES505723A0 (es) 1982-12-01
EP0049683A3 (de) 1982-09-01
KR830007667A (ko) 1983-11-04
ES8306487A1 (es) 1983-06-01
GB2084575A (en) 1982-04-15
EP0049683A2 (de) 1982-04-14
PT73726A (de) 1981-10-01
PT73726B (de) 1983-10-19
AU7559481A (en) 1982-04-01
FI812936L (fi) 1982-03-26
FI812936A7 (fi) 1982-03-26
DK421981A (da) 1982-03-26
IL63917A0 (en) 1981-12-31
ES514883A0 (es) 1983-06-01
GR75352B (member.php) 1984-07-13
PL233180A1 (en) 1983-02-14
DD204925A5 (de) 1983-12-14

Similar Documents

Publication Publication Date Title
ES8603455A1 (es) Un metodo para preparar derivados de piperazina
ES2066864T3 (es) Derivados de aralquilamina y fungicidas que los contienen.
DK51986D0 (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som insecticide midler
ES8303360A1 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina.
ES2046196T3 (es) Derivados de azacicloalcanos, promotores de absorcion que contienen los derivados como ingrediente eficaz y preparaciones externas que contienen los promotores de absorcion.
ES2111029T3 (es) Azaespiro(n,m)alcanos y diazaespiro(n,m)alcanos.
MX9307946A (es) Derivados de amina secundaria ciclica, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso.
ES8506718A1 (es) Un procedimiento para la preparacion de derivados benzoheterociclicos.
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
ES8609271A1 (es) Procedimiento para preparar derivados de carbamoilimidazol fungicidas
ES8302732A1 (es) Procedimiento para la obtencion de una 4-aminoimidazolo(4,5-c,7)-rifamicina sv o s.
SE8405588D0 (sv) New compounds
AR240815A2 (es) Procedimiento para preparar derivados de los acidos benzofuran-5-il y benzotiofen-5-il acetico y propionico
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
DE3877036D1 (de) Biologisch aktive verbindungen.
DK160271C (da) Analogifremgangsmaade til fremstilling af 5-halogenvinyl-uracil-derivater
FI884838A0 (fi) Nytt s-timololderivat och foerfarande foer dess framstaellning.
SE7609229L (sv) Medel for selektiv ogresbekempning i betor
ATE98235T1 (de) 2-thiazolidinon-derivate und diese enthaltende pharmazeutische praeparate, verfahren zu deren herstellung und deren verwendung.
ATE15667T1 (de) Neue substituierte 3,5-diamino-1,2,4-oxadiazole und 3,5-diamino-1,2,4-thiadiazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE1240T1 (de) Alpha-aminophenylessigsaeurederivate zur verwendung bei der behandlung von entzuendungen sowie neue alpha-aminophenylessigsaeurederivate.
SE7708452L (sv) Komposition innehallande en antrakinonforening
SE8904107D0 (sv) Kemiska foereningar
PH20920A (en) Flavene and thioflavene derivatives, pharmaceutical preparations that contain such compounds, and the use of the latter
ES2061490T3 (es) Derivados de perhidrotiazepina y perhidroazepina, su preparacion y uso en terapeutica.